Stock Traders Buy High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of some unusual options trading on Wednesday. Investors purchased 1,885 put options on the stock. This represents an increase of approximately 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Price Performance

Shares of NASDAQ:EVLO remained flat at $0.00 during trading hours on Friday. 58 shares of the company’s stock were exchanged, compared to its average volume of 1,491. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $0.76. The business’s 50-day moving average is $0.01 and its 200 day moving average is $0.03. The stock has a market cap of $8,542.35, a PE ratio of 0.00 and a beta of 1.29.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.